Larvol Delta

mericitabine (RG7128) - Gilead, Roche

Roche: Late-Stage Pipeline Event (Roche) - Oct 3, 2013 - Anticipated NME submission in EU and US for HCV in 2016 or later
Anticipated EU regulatory • Anticipated FDA event • Hepatitis C Virus

http://www.roche.com/investors/ir_agenda/late-stage_pipeline_2013.htm

Oct 3, 2013